A detailed history of Sulzberger Capital Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Sulzberger Capital Advisors, Inc. holds 914 shares of LLY stock, worth $808,469. This represents 0.99% of its overall portfolio holdings.

Number of Shares
914
Previous 1,632 44.0%
Holding current value
$808,469
Previous $1.26 Billion 40.08%
% of portfolio
0.99%
Previous 1.42%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 11, 2025

SELL
$725.72 - $929.72 $521,066 - $667,538
-718 Reduced 44.0%
914 $755 Million
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $1.19 Million - $1.52 Million
1,632 New
1,632 $1.26 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $840B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sulzberger Capital Advisors, Inc. Portfolio

Follow Sulzberger Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sulzberger Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sulzberger Capital Advisors, Inc. with notifications on news.